- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06908889
Karakterisering av bakteriell og mykose hudflora i seborrheic makulær hypopigmentation - mikrobiom (Microbiome_SHM)
Karakterisering av bakteriell og mykose hudflora i seborrheic makulær hypopigmentation - Microbiome_shm
Hypopigmented skin changes are commonly encountered by dermatologists. A new dermatological entity was identified as scattered, hypopigmented oval-shaped macules and patches distributed mostly in seborrheic area of the face and of the trunk in dark skinned individuals. This patterned presentation of hypopigmentation was first described in the literature under the name of hypochromic vitiligo or vitiligo minor. Nerveless, histopathological patient's specimens analyzed by Krueger et al. clearly highlight that there is no tangible causal correlation with a diagnosis of vitiligo. They propose to rename this entity to Seborrheic Macular Hypopigmentation (SMH). The etiopathology of this dermatosis is still unknown preventing to propose any satisfactory treatment for this disfiguring affection.The objective of this study is to analyze the bacterial and fungal skin microbiome on hypochromic lesions of SMH compared to the surrounding non-lesional skin of the same patients and to healthy volunteers
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, Frankrike, 06200
- CHU de Nice - Hôpital de l'Archet
-
-
Colmar
-
Colmar, Colmar, Frankrike, 68024
- Hôpital Louis Pasteur, hôpitaux Civils de Colmar
-
-
Île-de-France Region
-
Paris, Île-de-France Region, Frankrike, 75010
- Hôpital Saint-Louis - APHP
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Female and male patients ≥ 18 years of age
- Clinical diagnosis of SMH with lesion of the face
- Written informed consent obtained before any assessment is performed
- Affiliation with a social security scheme
- Physical and psychological ability to participate
Exclusion Criteria:
- Use of systemic antibiotics or any systemic antifungal treatments within 4 weeks before the inclusion visit
- Use of topical antibiotics or any topical antifungal treatments on the face within 2 weeks before the inclusion visit
- Use of any topical cream, gel, serum or ointment within 2 days before the inclusion visit
- Laser, radiofrequency, peeling or any other procedure on the face in the past 3 months before the inclusion visit
- Vulnerable patients: minors, patients under guardianship or curatorship, pregnant or breast-feeding women
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Diagnostisk
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Patients
The study population will consist of adult subjects (≥ 18 years) with Seborrheic Macular Hypopigmentation. |
Skin swabs will be obtained from the patient's facial lesional (FLS) and perilesional sites (FPS) using a sterile cotton swab. The microbiota of the same anatomical face regions will be collected on volunteers, once the 10 SMH patients have been enrolled. The swab is premoistened in a specific cocktail solution and rubbed onto the skin surface for 45sec. The pressure during the sampling involves rubbing the area of interest with a smear over the entire zone. The skin reddens slightly under the exerted pressure. |
|
Annen: Vulunteers
Volunteers will be included once the required number of SMP patients has been attained. Volunteers are going to be recruited only at the coordinator center, the CHU of Nice. Recruitment will be communicated to medical and/or Inserm staff, via an announcement in the respective departments. |
Skin swabs will be obtained from the patient's facial lesional (FLS) and perilesional sites (FPS) using a sterile cotton swab. The microbiota of the same anatomical face regions will be collected on volunteers, once the 10 SMH patients have been enrolled. The swab is premoistened in a specific cocktail solution and rubbed onto the skin surface for 45sec. The pressure during the sampling involves rubbing the area of interest with a smear over the entire zone. The skin reddens slightly under the exerted pressure. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
The bacterial skin microbiome of SMH patients vs voluntheers
Tidsramme: at baseline
|
For each sample, the bacterial profiles determined by real time PCR, will be described and compared as follows: seborrheic macular hypopigmented lesions versus same anatomic area in healthy volunteers. |
at baseline
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
The bacterial skin microbiome of SMH patients compare to the non-lesional surrounded skin of the same patients.
Tidsramme: at baseline
|
For each sample, the bacterial profiles determined by real time PCR, will be described and compared as follows: intra-individual hypochromic macula lesions versus perilesional areas located at least 1cm away from any hypopigmented macules. |
at baseline
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Thierry Passeron, PhD, CHU de Nice, Service de Dermatologie
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 24-PP-17
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .